Keywords: PGDS; RA; rheumatoid arthritis; RF; rheumatoid factor; ACPA; anti-citrullinated protein antibodies; AA; arachidonic acid; PG; prostaglandins; LT; leukotrienes; TX; thromboxanes; LX; lipoxins; NSAID; non steroidal anti-inflammatory drugs; COXIB; COX-2 selective
مقالات ISI PGDS (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PGDS; Aspirin-exacerbated respiratory disease (AERD); Asthma; Aspirin (acetylsalicylic acid, ASA); Chronic rhinosinusitis with nasal polyps; Nonsteroidal antiinflammatory drugs (NSAID); Hypersensitivity; Intolerance; AERD; aspirin-exacerbated respiratory diseas
Keywords: PGDS; Goat; L-PGDS; Reproductive system; Distribution;
Keywords: PGDS; AA; arachidonic acid; AKR; aldo-keto reductase; AOS; allene oxide synthase; CX; carbon numbers; COX; cyclooxygenase; cPGES; cytosolic PGE synthase; cPLA2; cytosolic phospholipase A2; CYP; cytochrome P450; DGLA; dihomo-γ-linolenic acid; DP; prostaglandin
Keywords: PGDS; L-PGDS; lipocalin-type prostaglandin D synthase; API; active pharmaceutical ingredient; BCS; biopharmaceutical classification system; SEM; scanning electron microscope; SE-HPLC; size exclusion high-performance liquid chromatography; CD; circular dichroism
Keywords: PGDS; Beta-trace protein; Prostaglandin D synthase; L-PGDS; Otitis media with effusion; Labyrinthine fluids; Perilymph;
DP1 receptor agonist, BW245C inhibits diet-induced obesity in ApoEâ/â mice
Keywords: PGDS; Obesity; ApoEâ/â mice; DP1 receptor agonist/antagonist; DP2 receptor agonist/antagonist; L-PGDS;
Lipocalin-type prostaglandin D2 synthase reduces glucagon secretion in alpha TC-1 clone 6 cells via the DP1 receptor
Keywords: PGDS; DP1 receptor; DP2 receptor; L-PGDS; Alpha TC-1 Clone 6 cells; Glucagon; Diabetes;
Bile acid elevation after Roux-en-Y gastric bypass is associated with cardio-protective effect in Zucker Diabetic Fatty rats
Keywords: PGDS; RYGB; Cardiovascular; ZDF rats; Bile acid; L-PGDS; Aortic wall thickness
Close teamwork between Nrf2 and peroxiredoxins 1 and 6 for the regulation of prostaglandin D2 and E2 production in macrophages in acute inflammation
Keywords: PGDS; AA; arachidonic acid; AP-1; activator protein-1; ARE; antioxidant-response element; BMDM; bone marrow-derived macrophage; COX-2; cyclooxygenase-2; DEX; dexamethasone; 15d-PGJ2; 15-deoxy-Î12,14-prostaglandin J2; ERK2; extracellular-regulated kinase 2; GST
Fine-tuned broad binding capability of human lipocalin-type prostaglandin D synthase for various small lipophilic ligands
Keywords: PGDS; PG; prostaglandin; L-PGDS; lipocalin-type prostaglandin D synthase; Kd; dissociation constant; ITC; isothermal titration calorimetry; T4; l-thyroxine; T3; 3,3â²,5-triiodo-l-thyronine; TNS; 2-(p-toluidinil) naphtalene-6-sulfonic acid; Binding thermodynami
Characteristic of PGDS potential regulation role on spermatogenesis in the Chinese mitten crab Eriocheir sinensis
Keywords: PGDS; PGDS; prostaglandin D synthase; GSH; glutathione; PGs; prostaglandins; PGD2; prostaglandin D2; COX; cyclooxygenase; L-PGDS; lipocalin-type PGD synthase; H-PGDS; hematopoietic PGD synthase; Es-PGDS; E. sinensis PGDS gene; sqPCR; semi-quantitative RT-PCR; q
Characterization of the oligomerization and ligand-binding properties of recombinant rat lipocalin 11
Keywords: PGDS; rLcn11; rat lipocalin 11; L-PGDS; lipocalin-type prostaglandin D synthase; OBP; odorant-binding protein; MUP; major urine protein; PBP; pheromone-binding proteins; WT; wild-type; LB; Luria-Bertani; IPTG; isopropyl β-d-thiogalactoside; MALDI-TOF; matrix-a
Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: Reversal by celecoxib
Keywords: PGDS; PGD2; prostaglandin D2; PGE2; prostaglandin E2; DP2; prostanoid receptor DP2; L-PGDS; lipocalin-prostaglandin (PG) D synthase; H-PGDS; hematopoietic-prostaglandin (PG) D synthase; NO; nitric oxide; COX-1 or Ptgs1; cyclooxygenase 1; COX-2 or Ptgs2; cycloox
Long-lasting changes in the cochlear K+ recycling structures after acute energy failure
Keywords: PGDS; SSNHL; sudden sensorineural hearing loss; 3NP; 3-nitropropionic acid; NKCC1; Na-K-Cl cotransporter isoform 1; Cx26; connexin 26; Kir4.1; an inwardly rectifying K+ channel; L-PGDS; lipocalin-type prostaglandin D synthase; ABR; auditory brainstem response;
Characterization of a new mPGES-1 inhibitor in rat models of inflammation
Keywords: PGDS; AIA; adjuvant-induced arthritis; COX; cyclooxygenase; DA; dark agouti; DMEM; Dulbecco's modified eagle medium; DMSO; dimethyl sulfoxide; FA; formic acid; FBS; fetal bovine serum; HRP; horseradish peroxidase; h-PGDS; hematopoietic prostaglandin D synthase;
Novel orexigenic pathway prostaglandin D2-NPY system - Involvement in orally active orexigenic δ opioid peptide
Keywords: PGDS; PGD2; DP1 receptor; NPY; Y1 receptor; COX-2; L-PGDS; δ Opioid receptor; Rubiscolin-6; Leptomeninges; Food intake;
Drug delivery system for poorly water-soluble compounds using lipocalin-type prostaglandin D synthase
Keywords: PGDS; L-PGDS; Lipid-transporter protein; Delivery vehicle; Protein drug interaction; Hydrophobic drug
Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells
Keywords: PGDS; L-PGDS; Lipocalin-type prostaglandin D2 synthase; MSCs; Mesenchymal stromal cells; PL; Platelet lysate; FCS; Fetal calf serum; PPARγ; Peroxisome proliferator-activated receptor gamma; CEBPα; CCAAT/enhancer binding protein alpha; FABP4; Fatty acid bindin
Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes
Keywords: PGDS; PG; prostaglandin; L-PGDS; lipocalin-type PGD synthase; COX; cyclooxygenase; 15d-PGJ2; 15-deoxy- Π12,14-prostaglandin J2; PPARγ; peroxisome proliferator-activated receptor γ; G418; geneticin; FBS; fetal bovine serum; RT-PCR; reverse transcriptase-poly
Development of enzyme-linked immunosorbent assay for Î12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase
Keywords: PGDS; PPARγ; peroxisome proliferator-activated receptor γ; PG; prostaglandin; 15d-PGJ2; 15-deoxy-Î12,14-prostaglandin J2; COX; cyclooxygenase; L-PGDS; lipocalin-type prostaglandin D synthase; ELISA; enzyme-linked immunosorbent assay; DME-HEPES; Dulbecco's mo
15-Deoxy-Î12,14-prostaglandin J2 interferes inducible synthesis of prostaglandins E2 and F2α that suppress subsequent adipogenesis program in cultured preadipocytes
Keywords: PGDS; PG; prostaglandin; PMA; phorbol 12-myristate 13-acetate; 15d-PGJ2; 15-deoxy-Î12,14-PGJ2; PPARγ; peroxisome proliferator-activated receptor γ; COX; cyclooxygenase; PDTC; pyrrolidinedithiocarbamate; NF-κB; nuclear factor-kappa B; L-PGDS; lipocalin-type
Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia
Keywords: PGDS; cerebral ischemia; middle cerebral artery occlusion; mouse; prostaglandins; PGD2; CBF; cerebral blood flow; COX; cyclooxygenase; H-PGDS; hematopoietic prostaglandin D synthase; L-PGDS; lipocalin-type prostaglandin D synthases; MABP; mean arterial blood pr
Suppression of adipogenesis program in cultured preadipocytes transfected stably with cyclooxygenase isoforms
Keywords: PGDS; PG; prostaglandin; COX; cyclooxygenase; 15d-PGJ2; 15-deoxy-Î12,14-PGJ2; PPARγ; peroxisome proliferator-activated receptor γ; L-PGDS; lipocalin-type PGD synthase; DME-HEPES; Dulbecco's modified Eagle's medium with 25 mM HEPES; FBS; fetal bovine serum
Seminal Plasma Lipocalin-Type Prostaglandin D Synthase: A Potential New Marker for the Diagnosis of Obstructive Azoospermia
Keywords: PGDS; testis; infertility; male; prostaglandin R2 D-isomerase; azoospermia; semen; FSH; follicle stimulating hormone; L-PGDS; lipocalin-type PGD synthase; NOA; nonobstructive azoospermia; OA; obstructive azoospermia; PGD; prostaglandin D;
Increased production of lipocalin-type prostaglandin D synthase in leptomeningeal cells through contact with astrocytes
Keywords: PGDS; Astrocytes; Leptomeninges; Co-culture; L-PGDS
Cooperative activation of lipocalin-type prostaglandin D synthase gene expression by activator protein-2β in proximal promoter and upstream stimulatory factor 1 within intron 4 in human brain-derived TE671 cells
Keywords: PGDS; PG; prostaglandin; L-PGDS; lipocalin-type PGD synthase; AP; activator protein; USF; upstream stimulatory factor; UTR; untranslated region; EMSA; electrophoretic mobility shift assay; ChIP; chromatin immunoprecipitation; siRNA; small interference RNA; N.C.
Purification of prostaglandin D synthase by ceramic- and size exclusion chromatography
Keywords: PGDS; Bovine and human cerebrospinal fluid (CSF); β-Trace protein; L-PGDS; Purification;
15d-PGJ2: The anti-inflammatory prostaglandin?
Keywords: PGDS; Prostaglandin; 15d-PGJ2; PPARγ; Inflammation; PGD2; H-PGDS; L-PGDS; NF-κB; Erk;